Publications by authors named "Fani Anatolitou"
The novel COVID-19 global pandemic has raised, among many others, major concerns regarding the impact of infection during pregnancy. Current evidence suggests that vertical transmission from mother to baby, antenatally or intrapartum, does occur, but is uncommon. According to the published reports of infants born to COVID-19-affected mothers, as well as the anecdotal experience of current practices worldwide, it appears that investigations regarding the potential of SARS-COV-2 vertical transmission in pregnancy have so far been based, to a large extent, on PCR testing of neonatal pharyngeal swab samples.
View Article and Find Full Text PDFBackground: Activin-A is a cytokine with a critical role in infections and associated inflammation in experimental models and humans. Still, the effects of activin-A on neonatal infections remain elusive. Here, we investigated the expression of activin-A in the serum of septicemic preterm and term neonates and in peripheral blood leukocytes stimulated with inflammatory agents in vitro.
View Article and Find Full Text PDFArticle Synopsis
- Patent ductus arteriosus (PDA) is a significant health issue in very low birth weight infants, treated variably across Europe with non-steroidal anti-inflammatory drugs (NSAIDs), but lacks standardized guidelines.
- A survey sent to neonatal intensive care units in 19 European countries revealed that intravenous indomethacin is the most commonly used NSAID, with varying practices for treatment duration and recurrence.
- The findings highlight the need for established guidelines to ensure consistent and equitable care for newborns with PDA throughout Europe.